Who Can Help Me when I Have Cancer?

Who Can Help Me when I Have Cancer?

Description:

Who Can Help Me when I Have Cancer? contains a helping hand of caring people and organizations you can contact RIGHT NOW:

Organizations that can give you financial support to help with your cancer treatment.
Organizations that will assist you in finding a sympathetic, supportive physician near you, one that is knowledgeable and open-minded on the use of natural and alternative cancer treatments.

Who Can Help Me when I Have Cancer?

Read More......

Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies

Prostate cancer : Signaling Network, Genetics, And New Treatment Strategies

by Richard G. Pestell, Marja T. Nevalainen
Paperback: 456 pages
Publisher: Humana Press; 1 edition (April 1, 2008)
Language: English

ISBN-10: 1-58829-741-1

ISBN-13: 978-1-58829-741-9

Award winning authors present a comprehensive review of new perspectives in prostate cancer research and open up new directions in the clinical management of prostate cancer. In, Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies, the authors focus on the biology, genetics, molecular signaling networks in the disease process, and recent advances in the treatment of prostate cancer. This state-of-the-art title provides key insights into cutting edge advances in prostate cancer research, such as laparoscopic radical prostatectomy, and offers a critical evaluation and discussion of opportunities for development of novel therapies for prostate cancer. Clinical trials that have not been covered or evaluated in any other books currently available are also discussed. Invaluable to physicians and researchers, Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies provides a comprehensive translational resource as well as an important source of information for prostate cancer patients.

Prostate cancer : Signaling Network, Genetics, And New Treatment Strategies

Read More......

Lung Cancer

Lung Cancer

Publisher:Wiley-Blackwell | Pages:480 | 2008-02-15 | ISBN: 1405151129 | PDF | 3.45 MB

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains these advances in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:

• Lung cancer susceptibility and risk assessment
• The pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinoma
• Screening for early detection
• Advances in molecular and genetic markers
• The detection and treatment of pre-neoplastic lesions and screening for lung cancer
• Novel therapies such as angiogenesis and multi-tyrosine kinase inhibitors

Lung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.

Lung Cancer

Read This E book

Lung Cancer Susceptibility Genes
Joan E. Bailey-Wilson

Introduction

After heart disease, cancer is the most common cause of death and lung cancer is the most common cause of cancer death in the United States [1]. From 1950 to 1988, lung cancer experienced the largest increase in mortality rate of all the cancers and lung cancer caused an estimated 146,000 deaths in the United States in 1992 [2]. Lung cancer became the
leading cause of cancer death in men in the early 1950s and in women in 1987. Cancer of the lung has frequently been cited as an example of a malignancy that is solely determined by the environment [3,4] and the risks associated with cigarette smoking [3–7] and certain occupations, such as mining [8], asbestos exposure, shipbuilding, and petroleum refining [9–14], are well
established. Most lung cancers are attributable to cigarette smoking (e.g. [15]). Dietary studies have found reduction in risk associated with high compared to low consumption of carotene-containing fruits and vegetables (for reviews see [16–19]). Atleast one recent, very large meta-analysis [20] has found significant protective effects of increased levels of dietary β-cryptoxanthin although recent trials of beta-carotene and vitamin A supplements have not shown any significant reduction in lung cancer risk; instead they showed an increased risk of lung cancer death in the treated group [21–24]. Environmental tobacco smoke (ETS, passive smoking) has also been shown to be associated with increased risk
of lung cancer (for review see [3,4,25–27]) with a recent prospective European study estimating that between 16 and 24%of lung cancers in nonsmokers and long-term ex-smokers were attributable to ETS [28]. A recent meta-analysis of 22 studies showed that exposure to workplace ETS increased risk of lung cancer in workers by 24% and that this risk was highly correlated with duration of exposure [29]. These environmental risk factors cannot be reviewed in detail here. There is little doubt that the majority of lung cancer cases are attributable to
(i.e., would not occur in the absence of) cigarette smoking and other behavioral and environmental risk factors [2,7,25,30]. However, some investigators have long hypothesized that individuals differ in their susceptibility to these environmental insults (e.g. [31–34]). It is well known that mutations and loss of heterozygosity at genetic loci such as oncogenes and tumor suppressor genes are involved in lung carcinogenesis (see [35,36] for reviews) but most of these changes are thought to be accumulated at the somatic cell level. However, evidence has been mounting that certain allelic variants at some genetic loci may affect susceptibility to lung cancer, although these effects may be small. Furthermore, mounting epidemiologic evidence has suggested lung cancer may show familial aggregation after adjusting for cigarette smoking and other risk factors, and that differential susceptibility to lung cancer may be inherited in a Mendelian fashion. There is evidence that both lung
cancer and smoking-associated cancer in general have an inherited genetic component, but the existence of such a genetic component has not been definitely proven. This chapter will detail the evidence Lung Cancer, 3rd edition. Edited by Jack A. Roth, James D. Cox, and Waun Ki Hong.

Read More......

Skin Cancer (2008)

Skin Cancer Second Edition (2008)

Skin Cancer
Publisher:Wiley | English | ISBN: 1405159618 | 536 pages | 2008 | PDF | 40 Mb

Description: The second edition of Skin Cancer: Recognition and Management is a definitive clinical reference which comprehensively examines the wide range of premalignant and malignant cutaneous disorder, including melanoma, Kaposi's sarcoma and other sarcomas, cutaneous lymphoma, cutaneous metastatic disease and cutaneous markers of internal malignancy, with emphasis on the most recent advances in diagnosis and management.

Fully revised and expanded, this new edition now includes full colour photographs and illustrations throughout to aid recognition and diagnosis, and covers the latest developments and treatment modalities. New chapters include:

* Merkel Cell Carcinoma

* Dermoscopy

Skin Cancer: Recognition and Management is a definitive clinical reference for dermatologist, oncologists, residents and any medical practitioner with an interest in skin cancer.

Skin Cancer (2008)

Read More......

Viral Therapy of Cancer

Viral Therapy of Cancer

• Publisher:John Wiley & Sons
• Language: English
• ISBN:0470019220
• 432 pages
• Data: 2008
• PDF
• 7 Mb

Description: n the last decade there has been an explosion of interest in viral therapies for cancer. Viral agents have been developed that are harmless to normal tissues but selectively able to kill cancer cells. These agents have been endowed with additional selectivity and potency through genetic manipulation. Increasingly these viruses are undergoing evaluation in clinical trials, both as single agents and in combination with standard chemotherapy and radiotherapy.

This book provides a comprehensive yet succinct overview of the current status of viral therapy of cancer. Chapters coherently present the advances made with individual agents and review the biological and clinical background to a range of viral therapies: structured to proceed from basic science at the bench to the patient’s bedside, they give an up-to-date and realistic evaluation of a therapy’s potential utility for the cancer patient.

* Presents state of the art knowledge on how viruses can be, and have been, used in novel therapeutic approaches for the treatment of cancer
* Describes the use of viruses as oncolytic agents, killing cells directly
* Editors are experts in the field, with experience of both laboratory and clinical research

Viral Therapy of Cancer is essential reading for both basic scientists and clinicians with an interest in viral therapy and gene therapy.

Viral Therapy of Cancer

Read More......

Breast Cancer Atlas of Clinical Oncology

Breast Cancer Atlas of Clinical Oncology

Breast Cancer Atlas of Clinical Oncology:
Part of the American Cancer Society's acclaimed Atlas of Clinical Oncology series, this volume offers an expert overview of breast cancer. Topics range from epidemiology and genetics to diagnosis, management and reconstruction. Post-treatment care, as well as male breast cancer, is also discussed. Key Features:

More than 300 color illustrations, photographs, and radiographs show tumors as they manifest
Discusses the latest techniques, such as image-directed biopsy and sentinel node biopsy
Includes contributions from leading surgeons, radiation oncologists, medical oncologists, and gynecologists
Accompanied by a CD-ROM with the complete text and illustrations of the book, in fully searchable PDF files
Images can be downloaded for lectures and presentations

Password : OHT-Forums
Breast Cancer Atlas of Clinical Oncology

Read More......

After Cancer Treatment: Heal Faster, Better, Stronger

After Cancer Treatment: Heal Faster, Better, Stronger

Publisher: The Johns Hopkins University Press; 1 edition
Language: English
ISBN: 0801884381
Paperback: 288 pages
Format: PDF

Description: At age 36, Julie Silver was enjoying an exciting career as a physician at the Harvard Medical School and a rewarding personal life as a mother, wife, and award-winning writer. But she had the sense that something was wrong. Two years and multiple doctors later, she was diagnosed with the breast cancer she had suspected all along and was catapulted into the role of cancer patient.

Like many cancer patients who experience serious side effects from treatment, Dr. Silver emerged from therapy feeling not better, but exhausted and physically devastated. As she worked to heal herself, she became determined to write a book to help others recover after cancer treatment.

Here Dr. Silver shares her own cancer journey and offers a step-by-step plan for physical healing, including exercise and diet recommendations and instructions for fighting fatigue, monitoring mood, and overcoming setbacks. Dr. Silver"s advice comes from the heart -- and from her experience as both a cancer survivor and a doctor who has spent her career helping people heal from serious illnesses and injuries. No matter where they are in their own journey with cancer, readers will find After Cancer Treatment a personal, practical, and powerful guide to recovery.

After Cancer Treatment: Heal Faster, Better, Stronger

Read More......